HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestlé Skin Health Has Suitors ‘Lining Up Around The Block’ After ‘Stunning’ Sales Turnaround

Executive Summary

Nestlé's once troubled Skin Health business is now a "leader in its space" after an astonishing turnaround, according to the Swiss firm's CEO. What's more, potential buyers for the unit are queuing out the door, waiting for Nestlé to kick off a much anticipated sale process.

You may also be interested in...



Private-Equity Investors Poised To Acquire Nestlé Skin Health, Promising US Expansion

After working hard to turnaround its troubled Skin Health dermatology operation, Nestlé looks set to offload the business to a consortium of private-equity buyers. The consortium - led by EQT - have identified expansion in the US consumer health market as an immediate priority.

Nestlé Expands Skin Health In Asia As Rumors Swirl of Impending Sale

With media reports suggesting Nestlé is about to kick off an auction for Skin Health, the Swiss food and drinks giant is expanding the business in Asia to take advantage of the growth opportunity it has spied in the region.

Nestlé Grows Health Offering With Global Deal for Anti-Aging Supplement

In line with its nutrition, health and wellness strategy, Nestlé has bolstered its consumer health offering with ChromaDex’ innovative energy boosting supplement.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel